source
- French regulator fines Novo Nordisk and Eli Lilly for misleading weight loss adsFrench medicines regulator ANSM imposed fines on Novo Nordisk and Eli Lilly for advertising practices linked to their weight loss drugs. Novo Nordisk was fined about $2 million for ads promoting W…
- Latus Bio raises $97 million to advance gene therapies for Huntington’s and Batten diseaseLatus Bio announced closing a $97 million Series A round, including a $43 million extension to a prior $54 million raise. Funding was led by 8VC and included eight other investors such as DCVC Bio…